Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru

A Llanos-Cuentas, G Tulliano… - Clinical infectious …, 2008 - academic.oup.com
… analysis of risk factors for treatment failure in patients with cutaneous leishmaniasis. … and
multivariate analysis of risk factors for treatment failure in patients with cutaneous leishmaniasis. …

Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination

H Silva, A Liyanage, T Deerasinghe… - PLoS …, 2021 - journals.plos.org
… In conclusion, this study characterises in detail the leishmaniasis treatment failures in Sri
Lanka initiating and encouraging further studies focusing on emerging drug resistance. Nearly …

… histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: a prospective case-control study on treatment …

M Bamorovat, I Sharifi, S Dabiri… - PLoS neglected …, 2021 - journals.plos.org
… related to anthroponotic cutaneous leishmaniasis (ACL) treatment outcome and resultant …
risk associated-factors in the development of treatment failure, relapse, and chronic forms of …

Risk factors for antimony treatment failure in American Cutaneous Leishmaniasis in Northwestern-Argentina

MF García-Bustos, G González-Prieto… - PLoS neglected …, 2021 - journals.plos.org
… , we observed meglumine antimoniate (MA) treatment failure (TF)-cases and a … cutaneous
cases together with the past cutaneous epidemics increased the ratio of mucosal to cutaneous

Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer

P Machado, C Araújo, AT Da Silva… - Clinical Infectious …, 2002 - academic.oup.com
… rate of treatment failure (46%) among patients with early-stage cutaneous leishmaniasis, …
for as many as 90% of patients with classic cutaneous leishmaniasis [8, 14]. In the present study…

Tackling drug resistance and other causes of treatment failure in leishmaniasis

GJ Wijnant, F Dumetz, L Dirkx, D Bulté… - Frontiers in Tropical …, 2022 - frontiersin.org
… If not asymptomatic (3), leishmaniasis presents itself as one of the following clinical forms:
(i) cutaneous leishmaniasis (CL), causing stigmatizing skin lesions and sometimes life-long …

[HTML][HTML] Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil

A Unger, S O'Neal, PRL Machado… - The American journal …, 2009 - ncbi.nlm.nih.gov
… We evaluated risk factors for treatment failure in patients with early and classic ulcerative
ACL. Patients (n = 136) were 13–60 years of age and had lesions with a duration of 15–90-days…

Drug resistance and treatment failure in leishmaniasis: A 21st century challenge

A Ponte-Sucre, F Gamarro, JC Dujardin… - PLoS neglected …, 2017 - journals.plos.org
treatment guidelines for Old and New World leishmaniasis is urgently needed on a global
basis because treatment failure … a fundamental determinant of treatment failure, although other …

[PDF][PDF] Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia …

R Palacios, LE Osorio, LF Grajalew… - The American journal of …, 2001 - academia.edu
… World cutaneous leishmaniasis, the response rate observed in this study for ten days of
treatment … of 88 to 100% for the treatment of cutaneous leishmaniasis caused by species of the …

Factors associated with treatmet failure of cutaneous leishmaniasis with meglumine antimoniate

AM Rodrigues, M Hueb, TARR Santos… - Revista da Sociedade …, 2006 - search.proquest.com
… factors associated with treatment failure in the treatment of cutaneous leishmaniasis with …
cutaneous leishmaniasis was built using medical records. The incidence of therapeutic failure